AGY Therapeutics enters several alliances to identify drug targets for CNS diseases and obesity July 2, 2001
BIBN-4096BS is a functionally selective CGRP receptor antagonist with potential in migraine Rx July 2, 2001
Dual-acting PPARgamma/PPARalpha agonist NNC-61-0029/(-)-DRF-2725: pharmacology and clinical PK July 2, 2001